Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Liver Cancer Expert Meeting Held in Hong Kong.

Cheung TT, Han HS, She WH, Chen KH, Chow PKH, Yoong BK, Lee KF, Kubo S, Tang CN, Wakabayashi G.

Liver Cancer. 2018 Mar;7(1):28-39. doi: 10.1159/000481834. Epub 2017 Dec 9.

2.

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.

Zhao Y, Shuen TWH, Toh TB, Chan XY, Liu M, Tan SY, Fan Y, Yang H, Lyer SG, Bonney GK, Loh E, Chang KTE, Tan TC, Zhai W, Chan JKY, Chow EK, Chee CE, Lee GH, Dan YY, Chow PK, Toh HC, Lim SG, Chen Q.

Gut. 2018 Mar 30. pii: gutjnl-2017-315201. doi: 10.1136/gutjnl-2017-315201. [Epub ahead of print]

3.

Initial experience with robotic hepatectomy in Singapore: analysis of 48 resections in 43 consecutive patients.

Goh BKP, Lee LS, Lee SY, Chow PKH, Chan CY, Chiow AKH.

ANZ J Surg. 2018 Mar 7. doi: 10.1111/ans.14417. [Epub ahead of print]

PMID:
29512261
4.

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.

Chow PKH, Gandhi M, Tan SB, Khin MW, Khasbazar A, Ong J, Choo SP, Cheow PC, Chotipanich C, Lim K, Lesmana LA, Manuaba TW, Yoong BK, Raj A, Law CS, Cua IHY, Lobo RR, Teh CSC, Kim YH, Jong YW, Han HS, Bae SH, Yoon HK, Lee RC, Hung CF, Peng CY, Liang PC, Bartlett A, Kok KYY, Thng CH, Low AS, Goh ASW, Tay KH, Lo RHG, Goh BKP, Ng DCE, Lekurwale G, Liew WM, Gebski V, Mak KSW, Soo KC; Asia-Pacific Hepatocellular Carcinoma Trials Group.

J Clin Oncol. 2018 Mar 2:JCO2017760892. doi: 10.1200/JCO.2017.76.0892. [Epub ahead of print]

PMID:
29498924
5.

Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma.

Chew V, Lee YH, Pan L, Nasir NJM, Lim CJ, Chua C, Lai L, Hazirah SN, Lim TKH, Goh BKP, Chung A, Lo RHG, Ng D, Filarca RLF, Albani S, Chow PKH.

Gut. 2018 Feb 13. pii: gutjnl-2017-315485. doi: 10.1136/gutjnl-2017-315485. [Epub ahead of print]

6.

Prospective study to determine early hypertrophy of the contra-lateral liver lobe after unilobar, Yttrium-90, selective internal radiation therapy in patients with hepatocellular carcinoma.

Teo JY, Allen JC, Ng DCE, Abdul Latiff JB, Choo SP, Tai DW, Low ASC, Cheah FK, Chang JPE, Kam JH, Lee VTW, Chung AYF, Chan CY, Chow PKH, Goh BKP.

Surgery. 2018 May;163(5):1008-1013. doi: 10.1016/j.surg.2017.10.014. Epub 2018 Jan 3.

PMID:
29306542
7.

A Retrospective Review of the Diagnostic and Management Challenges of Mirizzi Syndrome at the Singapore General Hospital.

Seah WM, Koh YX, Cheow PC, Chow PKH, Chan CY, Lee SY, Ooi LLPJ, Chung AYF, Goh BKP.

Dig Surg. 2017 Nov 30. doi: 10.1159/000484256. [Epub ahead of print]

PMID:
29190631
8.

Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.

Grinchuk OV, Yenamandra SP, Iyer R, Singh M, Lee HK, Lim KH, Chow PK, Kuznetsov VA.

Mol Oncol. 2018 Jan;12(1):89-113. doi: 10.1002/1878-0261.12153. Epub 2017 Dec 12.

9.

Radioembolisation of hepatocellular carcinoma: a primer.

Venkatanarasimha N, Gogna A, Tong KTA, Damodharan K, Chow PKH, Lo RHG, Chandramohan S.

Clin Radiol. 2017 Dec;72(12):1002-1013. doi: 10.1016/j.crad.2017.07.021. Epub 2017 Oct 9. Review.

PMID:
29032802
10.

The SIRveNIB and SARAH trials and the role of SIR-Spheres® Y-90 resin microspheres in the management of hepatocellular carcinoma.

Chow PK, Gandhi M, Gebski V.

Future Oncol. 2017 Oct;13(25):2213-2216. doi: 10.2217/fon-2017-0395. Epub 2017 Oct 4. No abstract available.

PMID:
28976206
11.

The Use of Bilayered Fascia Lata With an Interpositional Omental Flap for Autologous Repair of Contaminated Abdominal Fascial Defects.

Fong HC, Tan BK, Chow PK, Ong HS.

Ann Plast Surg. 2017 Nov;79(5):486-489. doi: 10.1097/SAP.0000000000001192.

PMID:
28953519
12.

Evolution of minimally invasive distal pancreatectomies at a single institution.

Goh BKP, Lee SY, Kam JH, Soh HL, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF, Chan CY.

J Minim Access Surg. 2018 Apr-Jun;14(2):140-145. doi: 10.4103/jmas.JMAS_26_17.

13.

Critical appraisal of the impact of individual surgeon experience on the outcomes of laparoscopic liver resection in the modern era: collective experience of multiple surgeons at a single institution with 324 consecutive cases.

Goh BKP, Teo JY, Lee SY, Kam JH, Cheow PC, Jeyaraj P, Chow PKH, Ooi LLPJ, Chung AYF, Chan CY.

Surg Endosc. 2018 Apr;32(4):1802-1811. doi: 10.1007/s00464-017-5864-7. Epub 2017 Sep 15.

PMID:
28916894
14.

Preoperative Prognostic Factors After Liver Resection for Non-Colorectal, Non-Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population.

Sim DPY, Goh BKP, Lee SY, Chan CY, Tan IBH, Cheow PC, Jeyaraj P, Chow PKH, Ooi LLPJ, Chung AYF.

World J Surg. 2018 Apr;42(4):1073-1084. doi: 10.1007/s00268-017-4208-z.

PMID:
28875334
15.

How to stay perfect: the role of memory and behavioural traits in an experienced problem and a similar problem.

Chow PKY, Lea SEG, Hempel de Ibarra N, Robert T.

Anim Cogn. 2017 Sep;20(5):941-952. doi: 10.1007/s10071-017-1113-7. Epub 2017 Jul 11.

16.

Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.

Chew V, Lai L, Pan L, Lim CJ, Li J, Ong R, Chua C, Leong JY, Lim KH, Toh HC, Lee SY, Chan CY, Goh BKP, Chung A, Chow PKH, Albani S.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5900-E5909. doi: 10.1073/pnas.1706559114. Epub 2017 Jul 3.

17.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh SY, Yu MC, Scarpa A, Lai J, Luo DX, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P.

Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.

18.

The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.

Pardo F, Sangro B, Lee RC, Manas D, Jeyarajah R, Donckier V, Maleux G, Pinna AD, Bester L, Morris DL, Iannitti D, Chow PK, Stubbs R, Gow PJ, Masi G, Fisher KT, Lau WY, Kouladouros K, Katsanos G, Ercolani G, Rotellar F, Bilbao JI, Schoen M.

Ann Surg Oncol. 2017 Sep;24(9):2465-2473. doi: 10.1245/s10434-017-5950-z. Epub 2017 Jun 26.

PMID:
28653161
19.

Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.

Zheng J, Chou JF, Gönen M, Vachharajani N, Chapman WC, Majella Doyle MB, Turcotte S, Vandenbroucke-Menu F, Lapointe R, Buettner S, Groot Koerkamp B, Ijzermans JNM, Chan CY, Goh BKP, Teo JY, Kam JH, Jeyaraj PR, Cheow PC, Chung AYF, Chow PKH, Ooi LLPJ, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Lee SY.

Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360.

PMID:
28650354
20.

Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors.

Nastase A, Teo JY, Heng HL, Ng CC, Myint SS, Rajasegaran V, Loh JL, Lee SY, Ooi LL, Chung AY, Chow PK, Cheow PC, Wan WK, Azhar R, Khoo A, Xiu SX, Alkaff SM, Cutcutache I, Lim JQ, Ong CK, Herlea V, Dima S, Duda DG, Teh BT, Popescu I, Lim TK.

Am J Cancer Res. 2017 Mar 1;7(3):484-502. eCollection 2017.

21.

Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.

Qamra A, Xing M, Padmanabhan N, Kwok JJT, Zhang S, Xu C, Leong YS, Lee Lim AP, Tang Q, Ooi WF, Suling Lin J, Nandi T, Yao X, Ong X, Lee M, Tay ST, Keng ATL, Gondo Santoso E, Ng CCY, Ng A, Jusakul A, Smoot D, Ashktorab H, Rha SY, Yeoh KG, Peng Yong W, Chow PKH, Chan WH, Ong HS, Soo KC, Kim KM, Wong WK, Rozen SG, Teh BT, Kappei D, Lee J, Connolly J, Tan P.

Cancer Discov. 2017 Jun;7(6):630-651. doi: 10.1158/2159-8290.CD-16-1022. Epub 2017 Mar 20.

PMID:
28320776
22.

The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma.

Zhai W, Lim TK, Zhang T, Phang ST, Tiang Z, Guan P, Ng MH, Lim JQ, Yao F, Li Z, Ng PY, Yan J, Goh BK, Chung AY, Choo SP, Khor CC, Soon WW, Sung KW, Foo RS, Chow PK.

Nat Commun. 2017 Feb 27;8:4565. doi: 10.1038/ncomms14565.

23.
24.

Touch screen assays of behavioural flexibility and error characteristics in Eastern grey squirrels (Sciurus carolinensis).

Chow PKY, Leaver LA, Wang M, Lea SEG.

Anim Cogn. 2017 May;20(3):459-471. doi: 10.1007/s10071-017-1072-z. Epub 2017 Jan 27.

25.

Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A single-institution experience with 176 patients.

Teo R, Goh BKP, Tai DWM, Allen JC, Lim TKH, Hwang JSG, Tan DM, Lee SY, Chan CY, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF, Ong S.

Surgery. 2017 May;161(5):1235-1245. doi: 10.1016/j.surg.2016.12.001. Epub 2017 Jan 19.

PMID:
28111046
26.

Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population.

Khaw KB, Choi RH, Kam JH, Chakraborty B, Chow PK.

Singapore Med J. 2017 Dec;58(12):703-707. doi: 10.11622/smedj.2016189. Epub 2016 Dec 20.

27.

A review of prognostic scores after liver resection in hepatocellular carcinoma: the MSKCC, SLICER and SSCLIP scores.

Chan EE, Chow PK.

Jpn J Clin Oncol. 2017 Apr 1;47(4):287-293. doi: 10.1093/jjco/hyw185. Review.

PMID:
27980082
28.

Evolution of laparoscopic liver resection at Singapore General Hospital: a nine-year experience of 195 consecutive resections.

Goh BK, Teo JY, Chan CY, Lee SY, Cheow PC, Chow PK, Ooi LL, Chung AY.

Singapore Med J. 2017 Dec;58(12):708-713. doi: 10.11622/smedj.2016188. Epub 2016 Dec 13.

29.

The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion.

Allen JC Jr, Nault JC, Zhu G, Khor AY, Liu J, Lim TK, Zucman-Rossi J, Chow PK.

Medicine (Baltimore). 2016 Nov;95(47):e5263.

30.

Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.

Gandhi M, Choo SP, Thng CH, Tan SB, Low AS, Cheow PC, Goh AS, Tay KH, Lo RH, Goh BK, Wong JS, Ng DC, Soo KC, Liew WM, Chow PK; Asia-Pacific Hepatocellular Carcinoma Trials Group.

BMC Cancer. 2016 Nov 7;16(1):856.

31.

Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity.

Lim A, Zhou J, Sinha RA, Singh BK, Ghosh S, Lim KH, Chow PK, Woon ECY, Yen PM.

Biochem Biophys Res Commun. 2016 Oct 21;479(3):476-481. doi: 10.1016/j.bbrc.2016.09.086. Epub 2016 Sep 17.

PMID:
27651333
32.

Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression.

Fong TT, Lok CN, Chung CY, Fung YM, Chow PK, Wan PK, Che CM.

Angew Chem Int Ed Engl. 2016 Sep 19;55(39):11935-9. doi: 10.1002/anie.201602814. Epub 2016 Aug 29.

PMID:
27571430
33.

Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.

Park HC, Yu JI, Cheng JC, Zeng ZC, Hong JH, Wang ML, Kim MS, Chi KH, Liang PC, Lee RC, Lau WY, Han KH, Chow PK, Seong J.

Liver Cancer. 2016 Jul;5(3):162-74. doi: 10.1159/000367766. Epub 2016 May 3.

34.

Factors associated with and consequences of open conversion after laparoscopic distal pancreatectomy: initial experience at a single institution.

Goh BKP, Chan CY, Lee SY, Chan WH, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF.

ANZ J Surg. 2017 Dec;87(12):E271-E275. doi: 10.1111/ans.13661. Epub 2016 Jul 21.

PMID:
27444856
35.

Preoperative platelet-to-lymphocyte ratio improves the performance of the international consensus guidelines in predicting malignant pancreatic cystic neoplasms.

Goh BK, Teo JY, Allen JC Jr, Tan DM, Chan CY, Lee SY, Tai DW, Thng CH, Cheow PC, Chow PK, Ooi LL, Chung AY.

Pancreatology. 2016 Sep-Oct;16(5):888-92. doi: 10.1016/j.pan.2016.06.660. Epub 2016 Jun 26.

PMID:
27421563
36.

National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma.

Chow PK, Choo SP, Ng DC, Lo RH, Wang ML, Toh HC, Tai DW, Goh BK, Wong JS, Tay KH, Goh AS, Yan SX, Loke KS, Thang SP, Gogna A, Too CW, Irani FG, Leong S, Lim KH, Thng CH.

Liver Cancer. 2016 Apr;5(2):97-106. doi: 10.1159/000367759. Epub 2016 Mar 17.

37.

Current role of selective internal radiation with yttrium-90 in liver tumors.

Lau WY, Teoh YL, Win KM, Lee RC, de Villa VH, Kim YH, Liang PC, Santos-Ocampo RS, Lo RH, Lim KB, Tai DW, Ng DC, Irani FG, Gogna A, Chow PK.

Future Oncol. 2016 May;12(9):1193-204. doi: 10.2217/fon-2016-0035. Epub 2016 Mar 23. Review. Erratum in: Future Oncol. 2016 Sep;12 (18):2174.

PMID:
27007495
38.

Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.

Tong AK, Kao YH, Too CW, Chin KF, Ng DC, Chow PK.

Br J Radiol. 2016 Jun;89(1062):20150943. doi: 10.1259/bjr.20150943. Epub 2016 Mar 24. Review.

39.

Laparoscopic Liver Resection for Tumors in the Left Lateral Liver Section.

Goh BK, Chan CY, Lee SY, Lee VT, Cheow PC, Chow PK, Ooi LL, Chung AY.

JSLS. 2016 Jan-Mar;20(1). pii: e2015.00112. doi: 10.4293/JSLS.2015.00112.

40.

Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.

Goh BK, Kam JH, Lee SY, Chan CY, Allen JC, Jeyaraj P, Cheow PC, Chow PK, Ooi LL, Chung AY.

J Surg Oncol. 2016 May;113(6):621-7. doi: 10.1002/jso.24197. Epub 2016 Feb 10.

PMID:
26861568
41.

A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.

Fu Y, Ong LC, Ranganath SH, Zheng L, Kee I, Zhan W, Yu S, Chow PK, Wang CH.

PLoS One. 2016 Feb 4;11(2):e0148123. doi: 10.1371/journal.pone.0148123. eCollection 2016.

42.

A comparison between robotic-assisted laparoscopic distal pancreatectomy versus laparoscopic distal pancreatectomy.

Goh BK, Chan CY, Soh HL, Lee SY, Cheow PC, Chow PK, Ooi LL, Chung AY.

Int J Med Robot. 2017 Mar;13(1). doi: 10.1002/rcs.1733. Epub 2016 Jan 27.

PMID:
26813478
43.

A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.

Teo JY, Allen JC Jr, Ng DC, Choo SP, Tai DW, Chang JP, Cheah FK, Chow PK, Goh BK.

HPB (Oxford). 2016 Jan;18(1):7-12. doi: 10.1016/j.hpb.2015.07.002. Epub 2015 Dec 11. Review.

44.

Correction: Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis.

Mah WC, Thurnherr T, Chow PK, Chung AY, Ooi LL, Toh HC, Teh BT, Saunthararajah Y, Lee CG.

PLoS One. 2016 Jan 11;11(1):e0146690. doi: 10.1371/journal.pone.0146690. eCollection 2016. No abstract available.

45.

Laparoscopic liver resection for posterosuperior and anterolateral lesions-a comparison experience in an Asian centre.

Teo JY, Kam JH, Chan CY, Goh BK, Wong JS, Lee VT, Cheow PC, Chow PK, Ooi LL, Chung AY, Lee SY.

Hepatobiliary Surg Nutr. 2015 Dec;4(6):379-90. doi: 10.3978/j.issn.2304-3881.2015.06.06.

46.

Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.

Goh BK, Chok AY, Allen JC Jr, Quek R, Teo MC, Chow PK, Chung AY, Ong HS, Wong WK.

Surgery. 2016 Apr;159(4):1146-56. doi: 10.1016/j.surg.2015.10.021. Epub 2015 Dec 11.

PMID:
26688506
47.

Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.

Goh BK, Teo JY, Chan CY, Lee SY, Jeyaraj P, Cheow PC, Chow PK, Ooi LL, Chung AY.

J Surg Oncol. 2016 Jan;113(1):89-93. doi: 10.1002/jso.24099. Epub 2015 Nov 26.

PMID:
26611492
48.

Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.

Wang W, Iyer NG, Tay HT, Wu Y, Lim TK, Zheng L, Song IC, Kwoh CK, Huynh H, Tan PO, Chow PK.

BMC Cancer. 2015 Oct 31;15:828. doi: 10.1186/s12885-015-1814-8.

49.

A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.

Teo JY, Allen JC Jr, Ng DC, Choo SP, Tai DW, Chang JP, Cheah FK, Chow PK, Goh BK.

HPB (Oxford). 2015 Oct 16. doi: 10.1111/hpb.12490. [Epub ahead of print] Review.

PMID:
26472490
50.

Analysis of colorectal cancer glyco-secretome identifies laminin β-1 (LAMB1) as a potential serological biomarker for colorectal cancer.

Lin Q, Lim HS, Lin HL, Tan HT, Lim TK, Cheong WK, Cheah PY, Tang CL, Chow PK, Chung MC.

Proteomics. 2015 Nov;15(22):3905-20. doi: 10.1002/pmic.201500236. Epub 2015 Oct 26.

PMID:
26359947

Supplemental Content

Support Center